Journey Medical Corp Cash and Restricted Cash
Journey Medical Corp (DERM) had Cash and Restricted Cash of $25.64 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-12
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $25.64M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $27.22M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.09M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $24.95M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $25.64M 10-Q · filed 2026-08-12 |
| 2026-03-31 | $27.22M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $24.09M 10-Q · filed 2026-08-12 |
| 2025-09-30 | $24.95M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $20.29M 10-Q · filed 2026-08-12 |
| 2025-03-31 | $21.07M 10-Q · filed 2026-05-13 |
| 2024-12-31 | $20.30M 10-Q · filed 2026-08-12 |
| 2024-09-30 | $22.46M 10-Q · filed 2025-11-12 |
| 2024-06-30 | $23.91M 10-Q · filed 2025-08-12 |
| 2024-03-31 | $24.06M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $27.44M 10-K · filed 2026-03-26 |
| 2023-09-30 | $24.75M 10-Q · filed 2024-11-12 |
| 2023-06-30 | $16.98M 10-Q · filed 2024-08-13 |
| 2023-03-31 | $26.10M 10-Q · filed 2024-05-14 |
| 2022-12-31 | $32.00M 10-K · filed 2025-03-27 |
| 2022-09-30 | $34.89M 10-Q · filed 2023-11-13 |
| 2022-06-30 | $38.14M 10-Q · filed 2023-08-10 |
| 2022-03-31 | $41.33M 10-Q · filed 2023-05-22 |
| 2021-12-31 | $49.08M 10-K · filed 2024-03-29 |
| 2021-09-30 | $21.69M 10-Q · filed 2022-11-10 |
| 2021-06-30 | $12.18M 10-Q · filed 2022-08-09 |
| 2021-03-31 | $19.00M 10-Q · filed 2022-05-10 |
| 2020-12-31 | $8.25M 10-K · filed 2023-03-31 |
| 2020-09-30 | $3.88M 10-Q · filed 2021-12-16 |
| 2019-12-31 | $4.80M 10-K · filed 2022-03-28 |